← 產業報告目錄
In-vitro Transcription Templates Market Size, Share & Trends Analysis Report By Disease Type (Cancer (Solid Tumors, Colorectal Cancer, NSCLC, Melanoma, Leukemia, Prostate Cancer, Others), Infectious Disease (Influenza, COVID-19, AIDS, Others), Lifestyle Disease, Genetic Disease, Others), By Treatment (Vaccine, Therapeutic), By Research Stage (Exploratory, Clinical), By End-User (Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academics & Research, Others), By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-28頁數 180報告編號 INSIGHTACE-5ed94e63b3
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 277.5 Mn as of 2023, the global In-vitro Transcription Templates Market is anticipated to climb to USD 1,134.1 Mn by 2031, reflecting a compound annual growth rate of 19.5% over the 2024–2031 period.
The In-vitro Transcription Templates sector involves essential for a range of research and diagnostic purposes. This domain has witnessed notable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Market momentum is supported by mounting need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global In-vitro Transcription Templates Market Snapshot
Chapter 4. Global In-vitro Transcription Templates Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Disease Type Estimates & Trend Analysis
5.1. by Disease Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Disease Type:
5.2.1. Cancer
5.2.1.1. Solid Tumors
5.2.1.2. Colorectal Cancer
5.2.1.3. NSCLC
5.2.1.4. Melanoma
5.2.1.5. Leukemia
5.2.1.6. Prostate Cancer
5.2.1.7. Others
5.2.2. Infectious Disease
5.2.2.1. Influenza
5.2.2.2. COVID-19
5.2.2.3. AIDS
5.2.2.4. Others
5.2.3. Lifestyle Disease
5.2.4. Genetic Disease
5.2.5. Others
Chapter 6. Market Segmentation 2: by Treatment Estimates & Trend Analysis
6.1. by Treatment & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Treatment:
6.2.1. Vaccine
6.2.2. Therapeutic
Chapter 7. Market Segmentation 3: by Research Stage Estimates & Trend Analysis
7.1. by Research Stage & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Research Stage:
7.2.1. Exploratory
7.2.2. Clinical
Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis
8.1. by End-user & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. CROs & CMOs
8.2.3. Academics & Research
8.2.4. Others
Chapter 9. In-vitro Transcription Templates Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.1.2. North America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
9.1.3. North America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Research Stage, 2023-2031
9.1.4. North America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
9.1.5. North America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.2. Europe
9.2.1. Europe In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.2.2. Europe In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
9.2.3. Europe In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Research Stage, 2023-2031
9.2.4. Europe In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
9.2.5. Europe In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.3. Asia Pacific
9.3.1. Asia Pacific In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.3.2. Asia Pacific In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
9.3.3. Asia-Pacific In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Research Stage, 2023-2031
9.3.4. Asia-Pacific In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
9.3.5. Asia Pacific In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.4. Latin America
9.4.1. Latin America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.4.2. Latin America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
9.4.3. Latin America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Research Stage, 2023-2031
9.4.4. Latin America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
9.4.5. Latin America In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2023-2031
9.5.2. Middle East & Africa In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
9.5.3. Middle East & Africa In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by Research Stage, 2023-2031
9.5.4. Middle East & Africa In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
9.5.5. Middle East & Africa In-vitro Transcription Templates Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific Inc.
10.2.2. Promega Corporation
10.2.3. Agilent Technologies, Inc.
10.2.4. New England Biolabs
10.2.5. Takara Bio Inc.
10.2.6. LGC Limited
10.2.7. Enzynomics Co. Ltd.
10.2.8. Enzo Life Sciences, Inc.
10.2.9. Danaher Corporation
10.2.10. Genscript Biotech Corporation
10.2.11. Eurofins Genomics LLC
10.2.12. TriLink Biotechnologies LLC
10.2.13. Bioline GMBH
10.2.14. Lucigen Corporation
10.2.15. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們